Medicare Scams Alert: Key Protections During Open Enrollment Period
Protect Medicare beneficiaries from scams during the Open Enrollment Period with key prevention and reporting guidelines including contact info for fraud reporting.
Protect Medicare beneficiaries from scams during the Open Enrollment Period with key prevention and reporting guidelines including contact info for fraud reporting.
Key Medicare telehealth flexibilities are set to expire September 30, 2025, amid stalled Congressional funding talks, risking rollback of virtual care policies and reimbursement.
Special Needs Plans (SNPs) enrollment now constitutes 21% of Medicare Advantage, driven by regulatory changes and payer concentration, amid overall MA market growth challenges.
Kettering Health in Ohio ends contracts with Medicare Advantage insurers Humana and Devoted Health due to payment and administrative issues, impacting patient plan options for 2026.
Solange De Lahongrais appointed as president of Puerto Rico Medicaid and Medicare Advantage Products Association, focusing on federal funding parity and program sustainability ahead of Medicaid funding expiration in 2027.
UnitedHealth Group, America's largest health insurer, navigates DOJ investigation and CEO changes while planning AI-driven cost reductions and premium hikes. Stock shows undervaluation amid demographic tailwinds.
UnitedHealth Group's stock has plummeted amid concerns over opaque financial reporting and Medicare Advantage upcoding investigations. Analysts demand greater transparency to assess future performance and regulatory impacts in the U.S. health insurance market.
Medicare Advantage plans saw a slower growth in administrative expenses in 2024, with detailed insights from the Sherlock Benchmarks revealing trends in cost drivers and plan management effectiveness.
SelectQuote faces a DOJ investigation and investor lawsuit over alleged deceptive Medicare Advantage sales practices, triggering a sharp stock decline and regulatory scrutiny.
SelectQuote faces a securities class-action lawsuit following DOJ intervention over alleged deceptive Medicare Advantage sales, impacting investor confidence and regulatory compliance in the insurance market.